nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR5—brainstem—multiple sclerosis	0.0153	0.0904	CbGeAlD
Octreotide—SSTR3—brainstem—multiple sclerosis	0.0146	0.0867	CbGeAlD
Octreotide—SSTR1—brainstem—multiple sclerosis	0.0116	0.0685	CbGeAlD
Octreotide—SSTR2—brainstem—multiple sclerosis	0.00983	0.0583	CbGeAlD
Octreotide—SSTR4—nervous system—multiple sclerosis	0.0094	0.0557	CbGeAlD
Octreotide—SSTR4—central nervous system—multiple sclerosis	0.00905	0.0537	CbGeAlD
Octreotide—SSTR3—nervous system—multiple sclerosis	0.00766	0.0454	CbGeAlD
Octreotide—SSTR5—cerebellum—multiple sclerosis	0.00752	0.0446	CbGeAlD
Octreotide—SSTR3—central nervous system—multiple sclerosis	0.00738	0.0437	CbGeAlD
Octreotide—SSTR1—midbrain—multiple sclerosis	0.00737	0.0437	CbGeAlD
Octreotide—SSTR3—cerebellum—multiple sclerosis	0.00721	0.0428	CbGeAlD
Octreotide—SSTR4—brain—multiple sclerosis	0.00719	0.0426	CbGeAlD
Octreotide—SSTR1—nervous system—multiple sclerosis	0.00606	0.0359	CbGeAlD
Octreotide—SSTR3—brain—multiple sclerosis	0.00586	0.0347	CbGeAlD
Octreotide—SSTR1—central nervous system—multiple sclerosis	0.00583	0.0346	CbGeAlD
Octreotide—SSTR1—cerebellum—multiple sclerosis	0.0057	0.0338	CbGeAlD
Octreotide—SSTR2—nervous system—multiple sclerosis	0.00515	0.0305	CbGeAlD
Octreotide—SSTR2—central nervous system—multiple sclerosis	0.00496	0.0294	CbGeAlD
Octreotide—SSTR2—cerebellum—multiple sclerosis	0.00485	0.0287	CbGeAlD
Octreotide—SSTR1—brain—multiple sclerosis	0.00463	0.0275	CbGeAlD
Octreotide—SSTR2—brain—multiple sclerosis	0.00394	0.0233	CbGeAlD
Octreotide—MPO—spinal cord—multiple sclerosis	0.00231	0.0137	CbGeAlD
Octreotide—MPO—nervous system—multiple sclerosis	0.00195	0.0116	CbGeAlD
Octreotide—MPO—central nervous system—multiple sclerosis	0.00188	0.0111	CbGeAlD
Octreotide—MPO—brain—multiple sclerosis	0.00149	0.00884	CbGeAlD
Octreotide—SSTR3—GPCR ligand binding—POMC—multiple sclerosis	0.000268	0.000656	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—S1PR1—multiple sclerosis	0.000267	0.000652	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000266	0.000651	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000263	0.000643	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GPR65—multiple sclerosis	0.000263	0.000642	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CCL2—multiple sclerosis	0.000262	0.000642	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000262	0.000641	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00026	0.000635	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GPC5—multiple sclerosis	0.000259	0.000634	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCL5—multiple sclerosis	0.000258	0.000631	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—POMC—multiple sclerosis	0.000257	0.000629	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL3—multiple sclerosis	0.000257	0.000628	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000256	0.000626	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CCR5—multiple sclerosis	0.000256	0.000626	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CCR2—multiple sclerosis	0.000256	0.000626	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CNR1—multiple sclerosis	0.000252	0.000617	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000252	0.000617	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000252	0.000615	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000251	0.000615	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL13—multiple sclerosis	0.00025	0.000613	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCR1—multiple sclerosis	0.00025	0.000613	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00025	0.000611	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—PTGER4—multiple sclerosis	0.000247	0.000605	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—RGS1—multiple sclerosis	0.000246	0.000601	CbGpPWpGaD
Octreotide—Infection—Triamcinolone—multiple sclerosis	0.000243	0.000576	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000243	0.000594	CbGpPWpGaD
Octreotide—Infection—Methylprednisolone—multiple sclerosis	0.000243	0.000575	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000242	0.000591	CbGpPWpGaD
Octreotide—Haematuria—Methotrexate—multiple sclerosis	0.000242	0.000572	CcSEcCtD
Octreotide—Shock—Triamcinolone—multiple sclerosis	0.000241	0.00057	CcSEcCtD
Octreotide—Insomnia—Prednisolone—multiple sclerosis	0.000241	0.00057	CcSEcCtD
Octreotide—Alopecia—Prednisone—multiple sclerosis	0.000241	0.00057	CcSEcCtD
Octreotide—Shock—Methylprednisolone—multiple sclerosis	0.00024	0.000569	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCR1—multiple sclerosis	0.00024	0.000587	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL13—multiple sclerosis	0.00024	0.000587	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00024	0.000568	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00024	0.000586	CbGpPWpGaD
Octreotide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00024	0.000567	CcSEcCtD
Octreotide—Loss of consciousness—Betamethasone—multiple sclerosis	0.000239	0.000566	CcSEcCtD
Octreotide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000239	0.000566	CcSEcCtD
Octreotide—Epistaxis—Methotrexate—multiple sclerosis	0.000239	0.000566	CcSEcCtD
Octreotide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000239	0.000566	CcSEcCtD
Octreotide—Paraesthesia—Prednisolone—multiple sclerosis	0.000239	0.000566	CcSEcCtD
Octreotide—Tachycardia—Triamcinolone—multiple sclerosis	0.000239	0.000566	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CXCR3—multiple sclerosis	0.000239	0.000584	CbGpPWpGaD
Octreotide—Mental disorder—Prednisone—multiple sclerosis	0.000239	0.000565	CcSEcCtD
Octreotide—Nausea—Azathioprine—multiple sclerosis	0.000238	0.000564	CcSEcCtD
Octreotide—Tachycardia—Methylprednisolone—multiple sclerosis	0.000238	0.000564	CcSEcCtD
Octreotide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000237	0.000562	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCL3—multiple sclerosis	0.000237	0.00058	CbGpPWpGaD
Octreotide—Malnutrition—Prednisone—multiple sclerosis	0.000237	0.000561	CcSEcCtD
Octreotide—Erythema—Prednisone—multiple sclerosis	0.000237	0.000561	CcSEcCtD
Octreotide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000237	0.00056	CcSEcCtD
Octreotide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000236	0.000559	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CNR1—multiple sclerosis	0.000236	0.000577	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000236	0.000577	CbGpPWpGaD
Octreotide—Convulsion—Betamethasone—multiple sclerosis	0.000236	0.000558	CcSEcCtD
Octreotide—Convulsion—Dexamethasone—multiple sclerosis	0.000236	0.000558	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCL3—multiple sclerosis	0.000236	0.000576	CbGpPWpGaD
Octreotide—Hypertension—Dexamethasone—multiple sclerosis	0.000235	0.000556	CcSEcCtD
Octreotide—Hypertension—Betamethasone—multiple sclerosis	0.000235	0.000556	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—GPR65—multiple sclerosis	0.000233	0.000569	CbGpPWpGaD
Octreotide—Asthenia—Mitoxantrone—multiple sclerosis	0.000233	0.000551	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CCR5—multiple sclerosis	0.000232	0.000568	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCR2—multiple sclerosis	0.000232	0.000568	CbGpPWpGaD
Octreotide—Myalgia—Dexamethasone—multiple sclerosis	0.000232	0.000549	CcSEcCtD
Octreotide—Myalgia—Betamethasone—multiple sclerosis	0.000232	0.000549	CcSEcCtD
Octreotide—Anxiety—Dexamethasone—multiple sclerosis	0.000231	0.000547	CcSEcCtD
Octreotide—Anxiety—Betamethasone—multiple sclerosis	0.000231	0.000547	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—IL2RA—multiple sclerosis	0.000229	0.00056	CbGpPWpGaD
Octreotide—Discomfort—Dexamethasone—multiple sclerosis	0.000229	0.000542	CcSEcCtD
Octreotide—Discomfort—Betamethasone—multiple sclerosis	0.000229	0.000542	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000228	0.000558	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—POMC—multiple sclerosis	0.000228	0.000558	CbGpPWpGaD
Octreotide—Pain—Prednisolone—multiple sclerosis	0.000228	0.000539	CcSEcCtD
Octreotide—Hepatitis—Methotrexate—multiple sclerosis	0.000228	0.000539	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000227	0.000555	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—RGS1—multiple sclerosis	0.000227	0.000554	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PTGER4—multiple sclerosis	0.000227	0.000554	CbGpPWpGaD
Octreotide—Pharyngitis—Methotrexate—multiple sclerosis	0.000226	0.000535	CcSEcCtD
Octreotide—Vision blurred—Prednisone—multiple sclerosis	0.000223	0.000529	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—PGR—multiple sclerosis	0.000223	0.000546	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCL2—multiple sclerosis	0.000223	0.000546	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000223	0.000528	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000223	0.000527	CcSEcCtD
Octreotide—Oedema—Dexamethasone—multiple sclerosis	0.000222	0.000526	CcSEcCtD
Octreotide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000222	0.000526	CcSEcCtD
Octreotide—Oedema—Betamethasone—multiple sclerosis	0.000222	0.000526	CcSEcCtD
Octreotide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000222	0.000526	CcSEcCtD
Octreotide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000222	0.000526	CcSEcCtD
Octreotide—MPO—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000222	0.000542	CbGpPWpGaD
Octreotide—Insomnia—Triamcinolone—multiple sclerosis	0.000221	0.000524	CcSEcCtD
Octreotide—Insomnia—Methylprednisolone—multiple sclerosis	0.000221	0.000523	CcSEcCtD
Octreotide—Infection—Betamethasone—multiple sclerosis	0.000221	0.000522	CcSEcCtD
Octreotide—Infection—Dexamethasone—multiple sclerosis	0.000221	0.000522	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00022	0.000539	CbGpPWpGaD
Octreotide—Ill-defined disorder—Prednisone—multiple sclerosis	0.00022	0.000521	CcSEcCtD
Octreotide—Paraesthesia—Triamcinolone—multiple sclerosis	0.00022	0.00052	CcSEcCtD
Octreotide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000219	0.000519	CcSEcCtD
Octreotide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000219	0.000519	CcSEcCtD
Octreotide—Visual impairment—Methotrexate—multiple sclerosis	0.000219	0.000519	CcSEcCtD
Octreotide—Anaemia—Prednisone—multiple sclerosis	0.000219	0.000519	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CXCR3—multiple sclerosis	0.000219	0.000535	CbGpPWpGaD
Octreotide—Shock—Betamethasone—multiple sclerosis	0.000219	0.000517	CcSEcCtD
Octreotide—Shock—Dexamethasone—multiple sclerosis	0.000219	0.000517	CcSEcCtD
Octreotide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000218	0.000517	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000218	0.000533	CbGpPWpGaD
Octreotide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000218	0.000516	CcSEcCtD
Octreotide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000218	0.000516	CcSEcCtD
Octreotide—Agitation—Prednisone—multiple sclerosis	0.000218	0.000516	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000218	0.000532	CbGpPWpGaD
Octreotide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000217	0.000515	CcSEcCtD
Octreotide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000217	0.000515	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CD28—multiple sclerosis	0.000217	0.00053	CbGpPWpGaD
Octreotide—Tachycardia—Betamethasone—multiple sclerosis	0.000217	0.000513	CcSEcCtD
Octreotide—Tachycardia—Dexamethasone—multiple sclerosis	0.000217	0.000513	CcSEcCtD
Octreotide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000215	0.00051	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000215	0.000526	CbGpPWpGaD
Octreotide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000215	0.000509	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—GPR65—multiple sclerosis	0.000215	0.000526	CbGpPWpGaD
Octreotide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000215	0.000508	CcSEcCtD
Octreotide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000215	0.000508	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCR2—multiple sclerosis	0.000214	0.000524	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CNR1—multiple sclerosis	0.000214	0.000524	CbGpPWpGaD
Octreotide—Malaise—Prednisone—multiple sclerosis	0.000214	0.000506	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCR2—multiple sclerosis	0.000213	0.000521	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL13—multiple sclerosis	0.000213	0.000521	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR1—multiple sclerosis	0.000213	0.000521	CbGpPWpGaD
Octreotide—Vertigo—Prednisone—multiple sclerosis	0.000213	0.000504	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000213	0.00052	CbGpPWpGaD
Octreotide—Syncope—Prednisone—multiple sclerosis	0.000213	0.000503	CcSEcCtD
Octreotide—Tinnitus—Methotrexate—multiple sclerosis	0.000212	0.000502	CcSEcCtD
Octreotide—Anorexia—Dexamethasone—multiple sclerosis	0.000212	0.000501	CcSEcCtD
Octreotide—Anorexia—Betamethasone—multiple sclerosis	0.000212	0.000501	CcSEcCtD
Octreotide—Urticaria—Prednisolone—multiple sclerosis	0.000211	0.000501	CcSEcCtD
Octreotide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000211	0.0005	CcSEcCtD
Octreotide—Fatigue—Triamcinolone—multiple sclerosis	0.000211	0.0005	CcSEcCtD
Octreotide—Fatigue—Methylprednisolone—multiple sclerosis	0.000211	0.000499	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—POMC—multiple sclerosis	0.00021	0.000515	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00021	0.000513	CbGpPWpGaD
Octreotide—Pain—Triamcinolone—multiple sclerosis	0.000209	0.000496	CcSEcCtD
Octreotide—Loss of consciousness—Prednisone—multiple sclerosis	0.000208	0.000493	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000206	0.000505	CbGpPWpGaD
Octreotide—Vomiting—Mitoxantrone—multiple sclerosis	0.000206	0.000488	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—CCL2—multiple sclerosis	0.000206	0.000503	CbGpPWpGaD
Octreotide—Immune system disorder—Methotrexate—multiple sclerosis	0.000206	0.000487	CcSEcCtD
Octreotide—Convulsion—Prednisone—multiple sclerosis	0.000205	0.000486	CcSEcCtD
Octreotide—Hypertension—Prednisone—multiple sclerosis	0.000205	0.000485	CcSEcCtD
Octreotide—Rash—Mitoxantrone—multiple sclerosis	0.000205	0.000484	CcSEcCtD
Octreotide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000204	0.000484	CcSEcCtD
Octreotide—Headache—Mitoxantrone—multiple sclerosis	0.000203	0.000481	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000202	0.000479	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000202	0.000479	CcSEcCtD
Octreotide—Arthralgia—Prednisone—multiple sclerosis	0.000202	0.000478	CcSEcCtD
Octreotide—Myalgia—Prednisone—multiple sclerosis	0.000202	0.000478	CcSEcCtD
Octreotide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000202	0.000478	CcSEcCtD
Octreotide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000201	0.000477	CcSEcCtD
Octreotide—Anxiety—Prednisone—multiple sclerosis	0.000201	0.000476	CcSEcCtD
Octreotide—Alopecia—Methotrexate—multiple sclerosis	0.000201	0.000476	CcSEcCtD
Octreotide—Insomnia—Betamethasone—multiple sclerosis	0.000201	0.000476	CcSEcCtD
Octreotide—Insomnia—Dexamethasone—multiple sclerosis	0.000201	0.000476	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.0002	0.000474	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—POMC—multiple sclerosis	0.0002	0.000489	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.0002	0.000473	CcSEcCtD
Octreotide—Paraesthesia—Betamethasone—multiple sclerosis	0.000199	0.000472	CcSEcCtD
Octreotide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000199	0.000472	CcSEcCtD
Octreotide—Discomfort—Prednisone—multiple sclerosis	0.000199	0.000472	CcSEcCtD
Octreotide—Mental disorder—Methotrexate—multiple sclerosis	0.000199	0.000472	CcSEcCtD
Octreotide—Malnutrition—Methotrexate—multiple sclerosis	0.000198	0.000469	CcSEcCtD
Octreotide—Erythema—Methotrexate—multiple sclerosis	0.000198	0.000469	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CNR1—multiple sclerosis	0.000198	0.000484	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CNR1—multiple sclerosis	0.000197	0.000481	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL13—multiple sclerosis	0.000197	0.000481	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR1—multiple sclerosis	0.000197	0.000481	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000196	0.00048	CbGpPWpGaD
Octreotide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000196	0.000464	CcSEcCtD
Octreotide—Dyspepsia—Betamethasone—multiple sclerosis	0.000196	0.000463	CcSEcCtD
Octreotide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000196	0.000463	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CCL5—multiple sclerosis	0.000195	0.000478	CbGpPWpGaD
Octreotide—Urticaria—Triamcinolone—multiple sclerosis	0.000194	0.00046	CcSEcCtD
Octreotide—Urticaria—Methylprednisolone—multiple sclerosis	0.000194	0.000459	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000194	0.000474	CbGpPWpGaD
Octreotide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000194	0.000458	CcSEcCtD
Octreotide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000193	0.000458	CcSEcCtD
Octreotide—Oedema—Prednisone—multiple sclerosis	0.000193	0.000458	CcSEcCtD
Octreotide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000193	0.000457	CcSEcCtD
Octreotide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000193	0.000457	CcSEcCtD
Octreotide—Decreased appetite—Betamethasone—multiple sclerosis	0.000193	0.000457	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CXCL10—multiple sclerosis	0.000193	0.000472	CbGpPWpGaD
Octreotide—Nausea—Mitoxantrone—multiple sclerosis	0.000193	0.000456	CcSEcCtD
Octreotide—Infection—Prednisone—multiple sclerosis	0.000192	0.000455	CcSEcCtD
Octreotide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000192	0.000454	CcSEcCtD
Octreotide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000192	0.000454	CcSEcCtD
Octreotide—Back pain—Methotrexate—multiple sclerosis	0.000192	0.000454	CcSEcCtD
Octreotide—Fatigue—Betamethasone—multiple sclerosis	0.000192	0.000453	CcSEcCtD
Octreotide—Fatigue—Dexamethasone—multiple sclerosis	0.000192	0.000453	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000191	0.000467	CbGpPWpGaD
Octreotide—Shock—Prednisone—multiple sclerosis	0.00019	0.000451	CcSEcCtD
Octreotide—Pain—Betamethasone—multiple sclerosis	0.00019	0.00045	CcSEcCtD
Octreotide—Pain—Dexamethasone—multiple sclerosis	0.00019	0.00045	CcSEcCtD
Octreotide—Nervous system disorder—Prednisone—multiple sclerosis	0.00019	0.000449	CcSEcCtD
Octreotide—Tachycardia—Prednisone—multiple sclerosis	0.000189	0.000447	CcSEcCtD
Octreotide—Skin disorder—Prednisone—multiple sclerosis	0.000188	0.000445	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000187	0.000458	CbGpPWpGaD
Octreotide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000187	0.000443	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—multiple sclerosis	0.000187	0.000442	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000186	0.000455	CbGpPWpGaD
Octreotide—Anorexia—Prednisone—multiple sclerosis	0.000184	0.000437	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000184	0.000435	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000183	0.000448	CbGpPWpGaD
Octreotide—Anaemia—Methotrexate—multiple sclerosis	0.000183	0.000433	CcSEcCtD
Octreotide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000183	0.000433	CcSEcCtD
Octreotide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000183	0.000433	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CCL5—multiple sclerosis	0.000183	0.000447	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000182	0.00043	CcSEcCtD
Octreotide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000182	0.00043	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—POMC—multiple sclerosis	0.000182	0.000444	CbGpPWpGaD
Octreotide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00018	0.000427	CcSEcCtD
Octreotide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00018	0.000426	CcSEcCtD
Octreotide—Malaise—Methotrexate—multiple sclerosis	0.000179	0.000423	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCL3—multiple sclerosis	0.000178	0.000436	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000178	0.000436	CbGpPWpGaD
Octreotide—Vertigo—Methotrexate—multiple sclerosis	0.000178	0.000421	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—CCL2—multiple sclerosis	0.000178	0.000434	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL10—multiple sclerosis	0.000177	0.000433	CbGpPWpGaD
Octreotide—Urticaria—Betamethasone—multiple sclerosis	0.000176	0.000418	CcSEcCtD
Octreotide—Urticaria—Dexamethasone—multiple sclerosis	0.000176	0.000418	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000176	0.000417	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—CCR5—multiple sclerosis	0.000176	0.000431	CbGpPWpGaD
Octreotide—Dizziness—Prednisolone—multiple sclerosis	0.000176	0.000417	CcSEcCtD
Octreotide—Asthenia—Triamcinolone—multiple sclerosis	0.000176	0.000416	CcSEcCtD
Octreotide—Body temperature increased—Betamethasone—multiple sclerosis	0.000176	0.000416	CcSEcCtD
Octreotide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000176	0.000416	CcSEcCtD
Octreotide—Abdominal pain—Betamethasone—multiple sclerosis	0.000176	0.000416	CcSEcCtD
Octreotide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000176	0.000416	CcSEcCtD
Octreotide—Asthenia—Methylprednisolone—multiple sclerosis	0.000175	0.000415	CcSEcCtD
Octreotide—Insomnia—Prednisone—multiple sclerosis	0.000175	0.000414	CcSEcCtD
Octreotide—Paraesthesia—Prednisone—multiple sclerosis	0.000174	0.000411	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000174	0.000424	CbGpPWpGaD
Octreotide—Pruritus—Triamcinolone—multiple sclerosis	0.000173	0.00041	CcSEcCtD
Octreotide—Cough—Methotrexate—multiple sclerosis	0.000173	0.000409	CcSEcCtD
Octreotide—Pruritus—Methylprednisolone—multiple sclerosis	0.000173	0.000409	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PTGER4—multiple sclerosis	0.000172	0.00042	CbGpPWpGaD
Octreotide—Convulsion—Methotrexate—multiple sclerosis	0.000172	0.000406	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCL3—multiple sclerosis	0.000171	0.000418	CbGpPWpGaD
Octreotide—Dyspepsia—Prednisone—multiple sclerosis	0.00017	0.000403	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PGR—multiple sclerosis	0.000169	0.000414	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000169	0.000413	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000169	0.000413	CbGpPWpGaD
Octreotide—Arthralgia—Methotrexate—multiple sclerosis	0.000169	0.000399	CcSEcCtD
Octreotide—Myalgia—Methotrexate—multiple sclerosis	0.000169	0.000399	CcSEcCtD
Octreotide—Chest pain—Methotrexate—multiple sclerosis	0.000169	0.000399	CcSEcCtD
Octreotide—Decreased appetite—Prednisone—multiple sclerosis	0.000168	0.000398	CcSEcCtD
Octreotide—Rash—Prednisolone—multiple sclerosis	0.000168	0.000397	CcSEcCtD
Octreotide—Dermatitis—Prednisolone—multiple sclerosis	0.000168	0.000397	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000167	0.000397	CcSEcCtD
Octreotide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000167	0.000396	CcSEcCtD
Octreotide—Fatigue—Prednisone—multiple sclerosis	0.000167	0.000395	CcSEcCtD
Octreotide—Headache—Prednisolone—multiple sclerosis	0.000167	0.000395	CcSEcCtD
Octreotide—Discomfort—Methotrexate—multiple sclerosis	0.000167	0.000395	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000166	0.000407	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCL5—multiple sclerosis	0.000166	0.000406	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCR3—multiple sclerosis	0.000166	0.000406	CbGpPWpGaD
Octreotide—Constipation—Prednisone—multiple sclerosis	0.000165	0.000392	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—CCR5—multiple sclerosis	0.000165	0.000403	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PTGER4—multiple sclerosis	0.000165	0.000403	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD28—multiple sclerosis	0.000164	0.000402	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000162	0.000397	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—PGR—multiple sclerosis	0.000162	0.000397	CbGpPWpGaD
Octreotide—Dizziness—Triamcinolone—multiple sclerosis	0.000162	0.000383	CcSEcCtD
Octreotide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000162	0.000383	CcSEcCtD
Octreotide—Dizziness—Methylprednisolone—multiple sclerosis	0.000162	0.000382	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCR2—multiple sclerosis	0.000161	0.000395	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—TYK2—multiple sclerosis	0.000161	0.000394	CbGpPWpGaD
Octreotide—Infection—Methotrexate—multiple sclerosis	0.000161	0.00038	CcSEcCtD
Octreotide—Feeling abnormal—Prednisone—multiple sclerosis	0.000159	0.000377	CcSEcCtD
Octreotide—Asthenia—Dexamethasone—multiple sclerosis	0.000159	0.000377	CcSEcCtD
Octreotide—Asthenia—Betamethasone—multiple sclerosis	0.000159	0.000377	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000159	0.000389	CbGpPWpGaD
Octreotide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000159	0.000375	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000158	0.000375	CcSEcCtD
Octreotide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000158	0.000375	CcSEcCtD
Octreotide—Nausea—Prednisolone—multiple sclerosis	0.000158	0.000374	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CD28—multiple sclerosis	0.000158	0.000385	CbGpPWpGaD
Octreotide—Pruritus—Dexamethasone—multiple sclerosis	0.000157	0.000372	CcSEcCtD
Octreotide—Pruritus—Betamethasone—multiple sclerosis	0.000157	0.000372	CcSEcCtD
Octreotide—Skin disorder—Methotrexate—multiple sclerosis	0.000157	0.000372	CcSEcCtD
Octreotide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000156	0.00037	CcSEcCtD
Octreotide—Vomiting—Triamcinolone—multiple sclerosis	0.000156	0.000369	CcSEcCtD
Octreotide—Vomiting—Methylprednisolone—multiple sclerosis	0.000155	0.000368	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CD86—multiple sclerosis	0.000155	0.000378	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCR2—multiple sclerosis	0.000155	0.000378	CbGpPWpGaD
Octreotide—Rash—Triamcinolone—multiple sclerosis	0.000154	0.000365	CcSEcCtD
Octreotide—Dermatitis—Triamcinolone—multiple sclerosis	0.000154	0.000365	CcSEcCtD
Octreotide—Anorexia—Methotrexate—multiple sclerosis	0.000154	0.000365	CcSEcCtD
Octreotide—Rash—Methylprednisolone—multiple sclerosis	0.000154	0.000365	CcSEcCtD
Octreotide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000154	0.000364	CcSEcCtD
Octreotide—Urticaria—Prednisone—multiple sclerosis	0.000154	0.000364	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCL5—multiple sclerosis	0.000153	0.000375	CbGpPWpGaD
Octreotide—Headache—Triamcinolone—multiple sclerosis	0.000153	0.000363	CcSEcCtD
Octreotide—Headache—Methylprednisolone—multiple sclerosis	0.000153	0.000362	CcSEcCtD
Octreotide—Abdominal pain—Prednisone—multiple sclerosis	0.000153	0.000362	CcSEcCtD
Octreotide—Body temperature increased—Prednisone—multiple sclerosis	0.000153	0.000362	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCL5—multiple sclerosis	0.000152	0.000373	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000152	0.000372	CbGpPWpGaD
Octreotide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000152	0.00036	CcSEcCtD
Octreotide—Diarrhoea—Betamethasone—multiple sclerosis	0.000152	0.00036	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CCL3—multiple sclerosis	0.000152	0.000371	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—POMC—multiple sclerosis	0.000152	0.000371	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00015	0.000367	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCR5—multiple sclerosis	0.00015	0.000366	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CNR1—multiple sclerosis	0.000149	0.000364	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—IL2—multiple sclerosis	0.000148	0.000361	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2RA—multiple sclerosis	0.000148	0.000361	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000147	0.000349	CcSEcCtD
Octreotide—Dizziness—Dexamethasone—multiple sclerosis	0.000147	0.000348	CcSEcCtD
Octreotide—Dizziness—Betamethasone—multiple sclerosis	0.000147	0.000348	CcSEcCtD
Octreotide—Insomnia—Methotrexate—multiple sclerosis	0.000146	0.000346	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PTGER4—multiple sclerosis	0.000146	0.000357	CbGpPWpGaD
Octreotide—Nausea—Triamcinolone—multiple sclerosis	0.000145	0.000344	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000145	0.000355	CbGpPWpGaD
Octreotide—Paraesthesia—Methotrexate—multiple sclerosis	0.000145	0.000344	CcSEcCtD
Octreotide—Nausea—Methylprednisolone—multiple sclerosis	0.000145	0.000344	CcSEcCtD
Octreotide—Dyspnoea—Methotrexate—multiple sclerosis	0.000144	0.000341	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PGR—multiple sclerosis	0.000144	0.000352	CbGpPWpGaD
Octreotide—Somnolence—Methotrexate—multiple sclerosis	0.000144	0.00034	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CNR1—multiple sclerosis	0.000143	0.000349	CbGpPWpGaD
Octreotide—Hypersensitivity—Prednisone—multiple sclerosis	0.000143	0.000337	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—multiple sclerosis	0.000142	0.000337	CcSEcCtD
Octreotide—Vomiting—Betamethasone—multiple sclerosis	0.000141	0.000334	CcSEcCtD
Octreotide—Vomiting—Dexamethasone—multiple sclerosis	0.000141	0.000334	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CXCR3—multiple sclerosis	0.000141	0.000345	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SPP1—multiple sclerosis	0.000141	0.000345	CbGpPWpGaD
Octreotide—Decreased appetite—Methotrexate—multiple sclerosis	0.000141	0.000333	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CCL3—multiple sclerosis	0.00014	0.000342	CbGpPWpGaD
Octreotide—Rash—Dexamethasone—multiple sclerosis	0.00014	0.000332	CcSEcCtD
Octreotide—Rash—Betamethasone—multiple sclerosis	0.00014	0.000332	CcSEcCtD
Octreotide—Dermatitis—Dexamethasone—multiple sclerosis	0.00014	0.000331	CcSEcCtD
Octreotide—Dermatitis—Betamethasone—multiple sclerosis	0.00014	0.000331	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CD28—multiple sclerosis	0.00014	0.000342	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00014	0.00033	CcSEcCtD
Octreotide—Fatigue—Methotrexate—multiple sclerosis	0.000139	0.00033	CcSEcCtD
Octreotide—Headache—Betamethasone—multiple sclerosis	0.000139	0.000329	CcSEcCtD
Octreotide—Headache—Dexamethasone—multiple sclerosis	0.000139	0.000329	CcSEcCtD
Octreotide—Asthenia—Prednisone—multiple sclerosis	0.000139	0.000329	CcSEcCtD
Octreotide—Pain—Methotrexate—multiple sclerosis	0.000138	0.000327	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000138	0.000338	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—POMC—multiple sclerosis	0.000138	0.000336	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR2—multiple sclerosis	0.000137	0.000336	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR5—multiple sclerosis	0.000137	0.000336	CbGpPWpGaD
Octreotide—Pruritus—Prednisone—multiple sclerosis	0.000137	0.000324	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000136	0.000333	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2RA—multiple sclerosis	0.000135	0.000331	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—PTGER4—multiple sclerosis	0.000135	0.00033	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL2—multiple sclerosis	0.000135	0.000329	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2—multiple sclerosis	0.000134	0.000328	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL10—multiple sclerosis	0.000134	0.000328	CbGpPWpGaD
Octreotide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000133	0.000315	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PGR—multiple sclerosis	0.000133	0.000325	CbGpPWpGaD
Octreotide—Diarrhoea—Prednisone—multiple sclerosis	0.000132	0.000313	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000132	0.000313	CcSEcCtD
Octreotide—Nausea—Dexamethasone—multiple sclerosis	0.000132	0.000312	CcSEcCtD
Octreotide—Nausea—Betamethasone—multiple sclerosis	0.000132	0.000312	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—POMC—multiple sclerosis	0.000132	0.000323	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCR3—multiple sclerosis	0.00013	0.000318	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000129	0.000316	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD28—multiple sclerosis	0.000129	0.000315	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—POMC—multiple sclerosis	0.000129	0.000315	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000129	0.000314	CbGpPWpGaD
Octreotide—Urticaria—Methotrexate—multiple sclerosis	0.000128	0.000304	CcSEcCtD
Octreotide—Dizziness—Prednisone—multiple sclerosis	0.000128	0.000303	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—multiple sclerosis	0.000128	0.000303	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—multiple sclerosis	0.000128	0.000303	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CCR2—multiple sclerosis	0.000127	0.00031	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CNR1—multiple sclerosis	0.000127	0.00031	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—APOE—multiple sclerosis	0.000125	0.000305	CbGpPWpGaD
Octreotide—Vomiting—Prednisone—multiple sclerosis	0.000123	0.000291	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—TYK2—multiple sclerosis	0.000122	0.000299	CbGpPWpGaD
Octreotide—Rash—Prednisone—multiple sclerosis	0.000122	0.000289	CcSEcCtD
Octreotide—Dermatitis—Prednisone—multiple sclerosis	0.000122	0.000289	CcSEcCtD
Octreotide—Headache—Prednisone—multiple sclerosis	0.000121	0.000287	CcSEcCtD
Octreotide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000119	0.000282	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—POMC—multiple sclerosis	0.000119	0.000291	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD86—multiple sclerosis	0.000117	0.000287	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000117	0.000287	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—POMC—multiple sclerosis	0.000117	0.000286	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CNR1—multiple sclerosis	0.000117	0.000286	CbGpPWpGaD
Octreotide—Asthenia—Methotrexate—multiple sclerosis	0.000116	0.000275	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCL5—multiple sclerosis	0.000115	0.000282	CbGpPWpGaD
Octreotide—Nausea—Prednisone—multiple sclerosis	0.000115	0.000272	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CCL2—multiple sclerosis	0.000114	0.00028	CbGpPWpGaD
Octreotide—Pruritus—Methotrexate—multiple sclerosis	0.000114	0.000271	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CXCL10—multiple sclerosis	0.000114	0.000279	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CD80—multiple sclerosis	0.000113	0.000276	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CD86—multiple sclerosis	0.000112	0.000275	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2—multiple sclerosis	0.000112	0.000274	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL5—multiple sclerosis	0.000111	0.000271	CbGpPWpGaD
Octreotide—Diarrhoea—Methotrexate—multiple sclerosis	0.000111	0.000262	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—POMC—multiple sclerosis	0.000108	0.000264	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000107	0.000263	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—POMC—multiple sclerosis	0.000107	0.000262	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—multiple sclerosis	0.000107	0.000261	CbGpPWpGaD
Octreotide—Dizziness—Methotrexate—multiple sclerosis	0.000107	0.000253	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCL2—multiple sclerosis	0.000106	0.000258	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CXCL10—multiple sclerosis	0.000105	0.000257	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCL2—multiple sclerosis	0.000105	0.000257	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCR5—multiple sclerosis	0.000104	0.000254	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TYK2—multiple sclerosis	0.000104	0.000254	CbGpPWpGaD
Octreotide—Vomiting—Methotrexate—multiple sclerosis	0.000103	0.000243	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—MAPK1—multiple sclerosis	0.000103	0.000251	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—multiple sclerosis	0.000103	0.000251	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2RA—multiple sclerosis	0.000103	0.000251	CbGpPWpGaD
Octreotide—Rash—Methotrexate—multiple sclerosis	0.000102	0.000241	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—multiple sclerosis	0.000102	0.000241	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL2—multiple sclerosis	0.000102	0.000249	CbGpPWpGaD
Octreotide—Headache—Methotrexate—multiple sclerosis	0.000101	0.00024	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CD86—multiple sclerosis	9.97e-05	0.000244	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCR5—multiple sclerosis	9.97e-05	0.000244	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2RA—multiple sclerosis	9.83e-05	0.00024	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL5—multiple sclerosis	9.82e-05	0.00024	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2—multiple sclerosis	9.75e-05	0.000239	CbGpPWpGaD
Octreotide—Nausea—Methotrexate—multiple sclerosis	9.6e-05	0.000227	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—TYK2—multiple sclerosis	9.59e-05	0.000235	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TYK2—multiple sclerosis	9.53e-05	0.000233	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—multiple sclerosis	9.53e-05	0.000233	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—APOE—multiple sclerosis	9.46e-05	0.000231	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD86—multiple sclerosis	9.2e-05	0.000225	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SPP1—multiple sclerosis	9.09e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—APOE—multiple sclerosis	9.07e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL5—multiple sclerosis	9.06e-05	0.000222	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCR5—multiple sclerosis	8.84e-05	0.000216	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—multiple sclerosis	8.79e-05	0.000215	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2RA—multiple sclerosis	8.72e-05	0.000213	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—multiple sclerosis	8.65e-05	0.000212	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD80—multiple sclerosis	8.56e-05	0.000209	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—multiple sclerosis	8.39e-05	0.000205	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CD80—multiple sclerosis	8.2e-05	0.000201	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR5—multiple sclerosis	8.16e-05	0.0002	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—POMC—multiple sclerosis	8.13e-05	0.000199	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—APOE—multiple sclerosis	8.05e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2RA—multiple sclerosis	8.04e-05	0.000197	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—multiple sclerosis	7.98e-05	0.000195	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CCL2—multiple sclerosis	7.95e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—multiple sclerosis	7.93e-05	0.000194	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL6—multiple sclerosis	7.89e-05	0.000193	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—POMC—multiple sclerosis	7.79e-05	0.000191	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—MAPK1—multiple sclerosis	7.78e-05	0.00019	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CCL2—multiple sclerosis	7.63e-05	0.000186	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—multiple sclerosis	7.51e-05	0.000184	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—MAPK1—multiple sclerosis	7.46e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—APOE—multiple sclerosis	7.43e-05	0.000182	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CD80—multiple sclerosis	7.27e-05	0.000178	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TYK2—multiple sclerosis	7.22e-05	0.000177	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TYK2—multiple sclerosis	6.92e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—POMC—multiple sclerosis	6.91e-05	0.000169	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—multiple sclerosis	6.76e-05	0.000165	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD80—multiple sclerosis	6.71e-05	0.000164	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—multiple sclerosis	6.67e-05	0.000163	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—MAPK1—multiple sclerosis	6.62e-05	0.000162	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—POMC—multiple sclerosis	6.38e-05	0.000156	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCL2—multiple sclerosis	6.24e-05	0.000153	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—multiple sclerosis	6.2e-05	0.000152	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—multiple sclerosis	6.19e-05	0.000151	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TYK2—multiple sclerosis	6.14e-05	0.00015	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—MAPK1—multiple sclerosis	6.11e-05	0.000149	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MAPK1—multiple sclerosis	6.07e-05	0.000148	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—multiple sclerosis	6.01e-05	0.000147	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—multiple sclerosis	5.98e-05	0.000146	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—multiple sclerosis	5.76e-05	0.000141	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—multiple sclerosis	5.73e-05	0.00014	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—multiple sclerosis	5.69e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TYK2—multiple sclerosis	5.67e-05	0.000139	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—multiple sclerosis	5.45e-05	0.000133	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—multiple sclerosis	5.11e-05	0.000125	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—multiple sclerosis	5.08e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—multiple sclerosis	5.06e-05	0.000124	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—multiple sclerosis	4.85e-05	0.000119	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—multiple sclerosis	4.84e-05	0.000118	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—multiple sclerosis	4.72e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—multiple sclerosis	4.7e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—multiple sclerosis	4.69e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—multiple sclerosis	4.69e-05	0.000115	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—multiple sclerosis	4.66e-05	0.000114	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MAPK1—multiple sclerosis	4.6e-05	0.000112	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—multiple sclerosis	4.51e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—multiple sclerosis	4.49e-05	0.00011	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—multiple sclerosis	4.46e-05	0.000109	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MAPK1—multiple sclerosis	4.41e-05	0.000108	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—multiple sclerosis	4.3e-05	0.000105	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—multiple sclerosis	4e-05	9.77e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—multiple sclerosis	3.99e-05	9.75e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—multiple sclerosis	3.97e-05	9.7e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MAPK1—multiple sclerosis	3.91e-05	9.56e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—multiple sclerosis	3.69e-05	9.02e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—multiple sclerosis	3.68e-05	8.99e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MAPK1—multiple sclerosis	3.61e-05	8.82e-05	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—multiple sclerosis	3.53e-05	8.64e-05	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—multiple sclerosis	3.39e-05	8.28e-05	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—multiple sclerosis	3e-05	7.34e-05	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—multiple sclerosis	2.77e-05	6.78e-05	CbGpPWpGaD
